blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0843566

EP0843566 - MEDICAMENT CARRIER FOR DRY POWDER INHALATOR AND PROCESS FOR FORMING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2001
Database last updated on 19.07.2024
Most recent event   Tooltip06.08.2004Lapse of the patent in a contracting state
New state(s): LU		published on 22.09.2004  [2004/39]
Applicant(s)For all designated states
GLAXO WELLCOME INC.
5 Moore Drive, Box 13398 Research Triangle Park
North Carolina 27709 / US
[N/P]
Former [1998/22]For all designated states
GLAXO WELLCOME INC.
5 Moore Drive, Box 13398
Research Triangle Park, North Carolina 27709 / US
Inventor(s)01 / VAN OORT, Michiel, M.
Glaxo Wellcome Inc., 5 Moore Drive
Research Triangle Park, NC 27709 / US
[1998/22]
Representative(s)Pike, Christopher Gerard
Pike & Co. Hayes Loft 68A Hayes Place
Marlow, Bucks. SL7 2BT / GB
[N/P]
Former [1999/52]Pike, Christopher Gerard
Pike & Co. Hayes Loft 68A Hayes Place
Marlow, Bucks. SL7 2BT / GB
Former [1998/22]Thornley, Rachel Mary
Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN / GB
Application number, filing date95937656.719.10.1995
[1998/22]
WO1995US13915
Priority number, dateUS1994032857821.10.1994         Original published format: US 328578
US1994032857721.10.1994         Original published format: US 328577
[1998/22]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9612515
Date:02.05.1996
Language:EN
[1996/20]
Type: A2 Application without search report 
No.:EP0843566
Date:27.05.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 02.05.1996 takes the place of the publication of the European patent application.
[1998/22]
Type: B1 Patent specification 
No.:EP0843566
Date:10.05.2000
Language:EN
[2000/19]
Search report(s)International search report - published on:EP01.08.1996
ClassificationIPC:A61M15/00
[1998/22]
CPC:
A61M15/0045 (EP); A61M15/00 (KR); A61M15/0048 (EP);
A61M15/005 (EP); A61M15/0051 (EP); A61M15/0055 (EP);
A61M2202/064 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/22]
Extension statesLT08.04.1997
LV08.04.1997
SI08.04.1997
TitleGerman:ARZNEIMITTELTRÄGER FÜR TROCKENPULVERINHALATOR UND VERFAHREN ZUR HERSTELLUNG DESSELBEN[1998/22]
English:MEDICAMENT CARRIER FOR DRY POWDER INHALATOR AND PROCESS FOR FORMING THE SAME[1998/22]
French:SUPPORT DE MEDICAMENT POUR INHALATEUR DE POUDRE SECHE ET SON PROCEDE DE FABRICATION[1998/22]
Entry into regional phase08.04.1997National basic fee paid 
08.04.1997Designation fee(s) paid 
08.04.1997Examination fee paid 
Examination procedure09.05.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
08.04.1997Examination requested  [1998/22]
15.12.1998Despatch of a communication from the examining division (Time limit: M04)
20.04.1999Reply to a communication from the examining division
22.07.1999Despatch of communication of intention to grant (Approval: No)
25.10.1999Despatch of communication of intention to grant (Approval: later approval)
17.11.1999Communication of intention to grant the patent
04.02.2000Fee for grant paid
04.02.2000Fee for publishing/printing paid
Divisional application(s)EP99121279.6  / EP0987041
Opposition(s)13.02.2001No opposition filed within time limit [2001/18]
Fees paidRenewal fee
10.10.1997Renewal fee patent year 03
12.10.1998Renewal fee patent year 04
14.10.1999Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT10.05.2000
BE10.05.2000
CH10.05.2000
GR10.05.2000
LI10.05.2000
NL10.05.2000
DK10.08.2000
PT10.08.2000
IE19.10.2000
LU19.10.2000
MC31.10.2000
[2004/39]
Former [2004/07]AT10.05.2000
BE10.05.2000
CH10.05.2000
GR10.05.2000
LI10.05.2000
NL10.05.2000
DK10.08.2000
PT10.08.2000
IE19.10.2000
MC31.10.2000
Former [2003/45]AT10.05.2000
BE10.05.2000
CH10.05.2000
LI10.05.2000
NL10.05.2000
DK10.08.2000
PT10.08.2000
IE19.10.2000
MC31.10.2000
Former [2003/09]AT10.05.2000
BE10.05.2000
CH10.05.2000
LI10.05.2000
NL10.05.2000
PT10.08.2000
IE19.10.2000
MC31.10.2000
Former [2002/42]AT10.05.2000
BE10.05.2000
CH10.05.2000
LI10.05.2000
PT10.08.2000
IE19.10.2000
MC31.10.2000
Former [2002/17]AT10.05.2000
BE10.05.2000
CH10.05.2000
LI10.05.2000
PT10.08.2000
IE19.10.2000
Former [2002/02]AT10.05.2000
BE10.05.2000
CH10.05.2000
LI10.05.2000
PT10.08.2000
Former [2001/16]AT10.05.2000
BE10.05.2000
PT10.08.2000
Former [2001/11]AT10.05.2000
BE10.05.2000
Cited inInternational search[AD]WO9013328  (RIKER LABORATORIES INC [US]) [AD] 1,5,8,12,15,18,19 * page 6, line 15 - line 20; claims 1,22 *;
 [A]WO9200115  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1,8,12,18 * claims 1,12 *;
 [A]US5101838  (SCHWARTZ HERMANN [CH], et al) [A] 9-11* claims 1-8 *;
 [A]WO9417679  (ADVANCED THERAPEUTIC PROD [US], et al) [A] 9-11 * page 19, line 11 - page 20, line 7 *;
 [AD]WO9420164  (TENAX CORP [US]) [AD] 1-3 * claims 1-7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.